COVER STORY
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
August 2, 2019
Indian pharma majors are reinventing themselves by launching specialty drugs and buying market access through acquisitions
2-august-2019
Outlook Business Magazine - August 2, 2019
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
Sewage treatment plants that mimic nature could heal our lakes, stop deaths in poorly aired sewage systems and save us money
After strengthening their presence online, e-commerce players sniff out a lucrative market offline
A well-managed insurance company turned out to be a risky stock to own. But it may be safe to set sail again, with Max Financial Services
In a rapidly changing digital world, mid-cap IT firms have more headroom to grow than large-caps
Netflix highlights the depth and width of its content library through a series of ten ads
Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs
The used car market in India is disrupting the auto industry, already vrooming ahead of new car sales
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
Sewage treatment plants that mimic nature could heal our lakes, stop deaths in poorly aired sewage systems and save us money
Sonant Technologies’ device empowers the speech-impaired by giving them a voice
After strengthening their presence online, e-commerce players sniff out a lucrative market offline
A well-managed insurance company turned out to be a risky stock to own. But it may be safe to set sail again, with Max Financial Services
In a rapidly changing digital world, mid-cap IT firms have more headroom to grow than large-caps
Netflix highlights the depth and width of its content library through a series of ten ads
Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs
The used car market in India is disrupting the auto industry, already vrooming ahead of new car sales